The Infectious Diseases Society of America has revised its guidance on treatment for people hospitalized with severe COVID-19 to include generic steroid pills in addition to Gilead Sciences' remdesivir. The update was made after the a study that found dexamethasone was associated with reduced mortality rates.
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.